Andrew C. Orth
CIK: 0001860010
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CTY
CITY THERAPEUTICS, INC.
DirectorOfficer
Discretionary Trading P&L
Holdings
About ORTH ANDREW C.
ORTH ANDREW C. (SEC CIK 0001860010) files insider reports with the SEC as President & CEO of CITY THERAPEUTICS, INC. (CTY).
Signal8 holds 2 ownership filings by ORTH ANDREW C. (1 Form 3, 1 Form 4), filed between Oct 15, 2026 and Oct 19, 2026. Those filings report 1 transaction, the latest on Oct 19, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on ORTH ANDREW C.'s filings is in CAMBRIDGE, MA.
Recent filings by ORTH ANDREW C.
- Oct 19, 2026: Grant or award of CTY derivative securities (Form 4, code A).
Other insiders filing for CITY THERAPEUTICS, INC. (CTY)
- ARCH Venture Partners XII, LLC, 10% Owner
- NELSEN ROBERT, Director
- MARAGANORE JOHN, Director
- Nochur Sara, Director
- Philip Ron M, Director
- Greene Barry E, Director